David is a successful healthcare investor and is actively involved in driving new strategic growth initiatives for Providence, helping to shape the future of one of America’s largest comprehensive health care organizations.

David joined Providence Ventures, an investment arm of Providence St. Joseph Health, as a Partner in 2018 where he has helped lead the formulation of the firm’s medical device, software, and digital health investment strategy. David previously served as President and Board Member of Mid-America Healthcare Investors Network, one of the largest healthcare venture capital industry groups in the U.S. Additionally, David served as a Principal helping to lead the healthcare practice of RC Capital and performed extensive sales, marketing, and financial training programs with Proctor & Gamble and Merrill Lynch.

As an investor, board member, and advisor, David has helped support talented healthcare entrepreneurs realize over $1 billion in value. Over his career, he has led or co-led investments in Bolder Surgical (sold), Veran Medical (sold), TissueTech (sold), Advanced Practice Strategies (sold), SurgiQuest (sold), TailorMed, MacroHealth, OrthAlign, and NICO Corporation. Additionally, David currently serves on the Board of Directors of DexCare, Wildflower Health, and AVIA Health.